SOLICITATION NOTICE
66 -- Analyzer
- Notice Date
- 6/29/2018
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Clinical Center/Office of Purchasing & Contracts, 6707 Democracy Blvd, Suite 106, MSC 5480, Bethesda, Maryland, 20892-5480
- ZIP Code
- 20892-5480
- Solicitation Number
- 18-012467
- Archive Date
- 7/18/2018
- Point of Contact
- Priscilla S. Abalos, Phone: 3015943879
- E-Mail Address
-
priscilla.abalos@nih.gov
(priscilla.abalos@nih.gov)
- Small Business Set-Aside
- Emerging Small Business
- Description
- • INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts (OPC) on behalf of the Department of Laboratory Medicine, Clinical Center (CC) at the National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to Agilent • NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE: The Intended procurement is classified under NAICS code 325414 with a Size Standard 1000 # of the employees. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-97 May 31, 2018. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($150,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION 1. Title: Scientific Supplies ( Analyzer) 2. Background Information: 1. Type of product or service to be acquired; The Department of Transfusion Medicine (DTM) core Next Generation Sequencing (NGS) research lab is prioritized to be established with the following objectives- • Characterization of emerging cell therapy products to improve safety, purity, potency, stability and efficacy. • To advance the nascent development and science of red cell genotyping. • For development and molecular validation of red cell antigen expression algorithms to improve transfusion safety. In order to ensure further analysis of safety prior to clinical scale use of experimental therapies, the DTM NGS core facility is being developed to research newer technologies to be incorporated into patient care. As part of this goal, we intend to purchase the Seahorse XFe96 Analyzer to test cell potency prior to clinical use. 2. Explanation for how the agency intends to use the product or service in terms of function to be performed; and As part of core cellular therapy manufacturing services, the DTM/CPS also offers core research support, including new research technologies to measure cellular safety, purity, potency and consistency. Traditional assays which are based on flow cytometry only provide superficial information about cell quality prior to infusion. Hence improved methods are needed to perform additional analysis prior to using these expensive experimental therapies in humans. The agilent Seahorse XFe96 Analyzers measure OCR and ECAR of live cells in a 96-well plate format. OCR and ECAR rates are key indicators of mitochondrial respiration and glycolysis and these measurements provide a systems-level view of cellular metabolic function in cultured cells and ex-vivo samples. 3. Performance requirement or essential physical characteristics. In order to operate at optimal levels and incorporate novel research technologies for clinical use, the following attributes of the Seahorse analyzer are critical to establish a new potency assay. Real-time Results, Live-Cell Responses, Flexible Assay Design for large numbers of cell therapy product screening, High Sensitivity, Compatibility, Mitochondrial function measurement, Metabolic phenotype measurement within a few hours, Glycolytic rate measurement, Quick determination of dependency of cellular energy production on mitochondrial substrates, 3D sample analysis- such as spheroids and islets, User friendly assay protocol development and analysis. Shipments will use government carrier at the expense of the government unless otherwise arranged. The contractor shall bear the cost of replacement for reagents and disposables found to be damaged or defective upon receipt by NIH or for incorrect or incomplete shipments. CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION The intended sole source is the only known source to meet the technical needs of the scientific equipment/supplies. The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by July 11, 2018 at 12:00 AM Eastern time and must reference solicitation number 18-012467. Responses may be submitted electronically to Priscilla Abalos, Contracting Specialist at Priscilla.abalos@nih.gov. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/CCOPC/18-012467/listing.html)
- Place of Performance
- Address: National Institute of Health, 9000 Rockville Pike, bldg. 10-3C-720D, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN04974833-W 20180701/180629231035-3bd659ec8fe1f5fbfa786a742f18deee (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |